HOME >> MEDICINE >> NEWS
Terrorist attacks increased dangerous irregular heartbeats

CHICAGO, Nov. 20 The rate of life-threatening heart rhythms more than doubled among New York heart patients the month after the September 11, 2001 terrorist attacks, researchers reported today at the American Heart Association's Scientific Sessions 2002.

The study evaluated patients with an implantable cardioverter-defibrillator (ICD). An ICD is an electrical generator the size of a pocket watch that is inserted into the heart to monitor heart rhythm. It detects life-threatening abnormal rhythms, called arrhythmias, and delivers an electrical shock to restore normal rhythm.

Beginning a few days after the terrorist attack on the World Trade Center, the rate of ICD discharges increased and remained elevated throughout the next month.

Researchers evaluated 200 patients (average age 69) with ICDs at six clinics within 100 miles of the World Trade Center. The devices had been implanted an average of 2.5 years before the terrorist attack.

ICDs can store monitoring data, allowing comparison of rhythm patterns and shock rates from different times. The researchers compared ICD discharge rates for the 30 days before and after the terrorist attack. In the month before the attack, 3.5 percent (seven patients) had heart rhythm disturbances that required electrical shocks from their ICDs. In the 30 days after the attack, 8 percent (16 patients) did a 2.3-fold increase.

The results provide compelling evidence of the impact of stress on the heart, says Marcin Kowalski, M.D., a resident at St. Luke's-Roosevelt Hospital Center in New York. Even more important, the findings demonstrate the life-saving value of ICDs, he says.

"These patients all had potentially lethal arrhythmias in the 30 days after the attack, and they were all successfully treated by ICDs," Kowalski says. "This is just another example showing that patients really benefit from ICDs and that ICDs can help save lives."

Previous studies have evaluated how stressful
'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
20-Nov-2002


Page: 1 2 3

Related medicine news :

1. Extreme exertion, emotion can spark repeat heart attacks
2. Blood pressure treatment could cut risk of strokes and heart attacks
3. Plant derivative attacks the roots of leukemia
4. High levels of airborne mouse allergen in inner-city homes could trigger asthma attacks
5. Patients with previous heart attacks may not benefit from pacemaker implant
6. Time to develop new antidotes for chemical attacks, urge researchers
7. Can we learn new tricks from an old drug in treating heart attacks?
8. Stem cell therapy effectively treats heart attacks in animals
9. Low cost drug helps reduce deaths, repeat heart attacks
10. Prescriptions for antibiotics to prevent anthrax uncommon after the 2001 anthrax attacks
11. New imaging technique may help reduce risk of heart attacks, strokes

Post Your Comments:
(Date:5/21/2013)... (PRWEB) May 21, 2013 Arizona ... inventors who want to develop their ideas into ... program. , The university is recruiting participants ... new “formation space” that provides early-stage entrepreneurs with ... AREA48 is open to anyone, ASU is particularly ...
(Date:5/21/2013)... Diversity Focus, a non-profit organization striving to improve ... the Creative Corridor region, is releasing results for its ... on Thursday, May 23rd at 10:30 a.m. The ... , The survey is a critical component to ... attract, nurture and retain people of diverse backgrounds, cultures ...
(Date:5/21/2013)... Boston, Mass.By studying the roles two proteins, thrombospondin-1 ... trans-Atlantic research team has identified a five-amino acid ... in mouse models of prostate, breast and lung ... could potentially block metastasis in a variety of ... Randolph Watnick, PhD, at Boston Children,s Hospital, Vivek ...
(Date:5/21/2013)... 2013 The nation’s first trial involving ... nearing its conclusion in Washington state court, Bernstein Liebhard ... yesterday, an attorney for the Plaintiffs compared Intuitive Surgical ... tie sales and services for its customers. ... control of surgeons, to keep control of hospitals and ...
(Date:5/21/2013)... A new study appearing in the current ... cells harvested from fat (adipose) are more potent than ... the body’s immune system. , The finding could ... adipose tissue-derived stem cells (AT-SCs) are far more plentiful ... and can be collected from waste material from liposuction ...
Breaking Medicine News(10 mins):Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:Changing cancer's environment to halt its spread 2Health News:Changing cancer's environment to halt its spread 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 2Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 3
(Date:5/21/2013)... Calif. , May 21, 2013 ... and manufacture of wireless personal healthcare products and ... its reach, announcing the release of two new ... blood pressure monitors and scales: the Wireless Pulse ... (Photo: http://photos.prnewswire.com/prnh/20130521/SF17618 ) ...
(Date:5/21/2013)... May 21, 2013 BioElectronics Corp. (PINKSHEETS: ... electronic devices, announced that CEO, Andrew ... the FDA,s Medical Advisory Committee, Orthopedic and Rehabilitation ... for over the counter sales. "It,s ... medical device classification schema," Whelan said.  "While the ...
(Date:5/21/2013)... and TARRYTOWN, N.Y. , ... NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today ... published online the positive Phase 2a study results ...  Dupilumab is an investigational monoclonal antibody targeting the alpha ... modulates signaling of both IL-4 and IL-13, drivers of ...
Breaking Medicine Technology:iHealth Lab adds new products and partners to mobile personal healthcare offering 2iHealth Lab adds new products and partners to mobile personal healthcare offering 3BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7
Cached News: